2000
DOI: 10.1089/end.2000.14.79
|View full text |Cite
|
Sign up to set email alerts
|

Urethral Devices for Managing Stress Urinary Incontinence

Abstract: Although surgery remains the gold standard for managing the majority of patients with stress urinary incontinence or retention, not all patients are suitable candidates or desire surgery. For these patients, several urethral caps and inserts are available, which are described. In approximately 50% of patients, satisfactory control is achieved. Further investigation undoubtedly will yield better devices to serve the large number of patients with urinary control problems.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2001
2001
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 4 publications
0
9
0
Order By: Relevance
“…In stress incontinence approximately 50% achieved satisfactory control [68] (III). Bacteriuria, which is usually asymptomatic, occurs in 10-35% of patients [68][69][70][71][72][73][74][75] (III). There are no well-designed studies investigating the significance of bacteriuria or symptomatic UTI in correlation with various urethral inserts and stents in comparison with other drainage methods.…”
Section: Urethral Stents/prosthesesmentioning
confidence: 98%
“…In stress incontinence approximately 50% achieved satisfactory control [68] (III). Bacteriuria, which is usually asymptomatic, occurs in 10-35% of patients [68][69][70][71][72][73][74][75] (III). There are no well-designed studies investigating the significance of bacteriuria or symptomatic UTI in correlation with various urethral inserts and stents in comparison with other drainage methods.…”
Section: Urethral Stents/prosthesesmentioning
confidence: 98%
“…The only information on the Femsoft ® insert (Fig. 7) was recently published by Elliott and Boone [25], who reported values given by the manufacturer. The continence rates were good, with a high satisfaction rate of 85% in patients using the device.…”
Section: Mini‐devices and Capsmentioning
confidence: 99%
“…On the other hand, endo‐urethral AUS consist of miniaturized devices, featured by significantly smaller invasiveness, placed inside the urethral canal by an endo‐luminal procedure with standard urinary tools under local or total anesthesia or by self‐insertion by the patient. Only a few endo‐urethral solutions are currently on the market, such as the Reliance System (UroMed Inc.) 8 and the FemSoft Insert (Rochester Medical Corp.) 9 …”
Section: Introductionmentioning
confidence: 99%
“…Regarding the AUS reported in Reference 10, the main component subjected to a risk of functional failure due to encrustations is the polymeric valve, made of polydimethylsiloxane (PDMS) 12 . Anyhow, there are many other endo‐urethral devices based on silicone 9 . Thus, assessing the functionality over time of silicone components (the PDMS valve in this case) would provide important hints on the possible long‐term stability of these devices in the urinary system.…”
Section: Introductionmentioning
confidence: 99%